Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Checklist of Responsibilities for the Scientific Editor of This Article
Publishing Process of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3348)
All Articles published online
|
Publishing Process of This Article
|
Apr 15, 2016 (publication date) through Dec 15, 2019
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Oncology
ISSN
1948-5204
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| Number | Cited Articles |
| 1 |
Anna Angelousi, Gregory Kaltsas, Anna Koumarianou, Martin O. Weickert, Ashley Grossman. Chemotherapy in NETs: When and how. Reviews in Endocrine and Metabolic Disorders 2017; 18(4): 485 doi: 10.1007/s11154-017-9432-1
|
| 2 |
Francesco Tonelli, Francesca Marini, Francesca Giusti, Maria Luisa Brandi. Gastro-entero-pancreatic neuroendocrine tumors in multiple endocrine neoplasia type 1: a therapy update. International Journal of Endocrine Oncology 2017; 4(1): 43 doi: 10.2217/ije-2016-0017
|
| 3 |
Silvia Martina Ferrari, Marco Centanni, Camilla Virili, Mario Miccoli, Paola Ferrari, Ilaria Ruffilli, Francesca Ragusa, Alessandro Antonelli, Poupak Fallahi. Sunitinib in the Treatment of Thyroid Cancer. Current Medicinal Chemistry 2019; 26(6): 963 doi: 10.2174/0929867324666171006165942
|
| 4 |
Martina Ferrata, Arno Schad, Stefanie Zimmer, Thomas J. Musholt, Katharina Bahr, Julian Kuenzel, Sven Becker, Erik Springer, Wilfried Roth, Matthias M. Weber, Christian Fottner. PD-L1 Expression and Immune Cell Infiltration in Gastroenteropancreatic (GEP) and Non-GEP Neuroendocrine Neoplasms With High Proliferative Activity. Frontiers in Oncology 2019; 9 doi: 10.3389/fonc.2019.00343
|
| 5 |
Anna Kathrin Stueven, Antonin Kayser, Christoph Wetz, Holger Amthauer, Alexander Wree, Frank Tacke, Bertram Wiedenmann, Christoph Roderburg, Henning Jann. Somatostatin Analogues in the Treatment of Neuroendocrine Tumors: Past, Present and Future. International Journal of Molecular Sciences 2019; 20(12): 3049 doi: 10.3390/ijms20123049
|
| 6 |
Konstantinos Chouliaras, Naeem A Newman, Mrinal Shukla, Katrina R Swett, Edward A Levine, Jonathan Sham, Gary N Mann, Perry Shen. Analysis of recurrence after the resection of pancreatic neuroendocrine tumors. Journal of Surgical Oncology 2018; 118(3): 416 doi: 10.1002/jso.25146
|
| 7 |
Pengchen Chen, Qingshui Wang, Jianwei Xie, Hang Fai Kwok. Signaling networks and the feasibility of computational analysis in gastroenteropancreatic neuroendocrine tumors. Seminars in Cancer Biology 2019; 58: 80 doi: 10.1016/j.semcancer.2019.04.005
|
| 8 |
Shan Wu, Jianjun Zhou, Jing Guo, Zhan Hua, Jianchen Li, Zai Wang. Apatinib inhibits tumor growth and angiogenesis in PNET models. Endocrine Connections 2019; : 8 doi: 10.1530/EC-18-0397
|
| 9 |
Jasmine Shell, Xavier M Keutgen, Corina Millo, Naris Nilubol, Dhaval Patel, Samira Sadowski, Myriem Boufraqech, Lily Yang, Roxanne Merkel, Christine Atallah, Peter Herscovitch, Electron Kebebew. 68-Gallium DOTATATE scanning in symptomatic patients with negative anatomic imaging but suspected neuroendocrine tumor. International Journal of Endocrine Oncology 2018; 5(1): IJE04 doi: 10.2217/ije-2017-0005
|
| 10 |
Yulong Li, William F Simonds. Recent advances in the management of endocrine malignancies associated with hereditary hyperparathyroidism syndromes. International Journal of Endocrine Oncology 2017; 4(2): 85 doi: 10.2217/ije-2016-0018
|
| 11 |
N. A. Maistrenko, P. N. Romashchenko, R. V. Orlova, M. V. Lysanyuk. Possibilities of treating patients with generalized neuroendocrine tumors. Onkologiya. Zhurnal imeni P.A.Gertsena 2018; 7(2): 16 doi: 10.17116/onkolog20187216-25
|
| 12 |
Hiroki Ueda, Yoshimitsu Akiyama, Shu Shimada, Kaoru Mogushi, Misaki Serizawa, Satoshi Matsumura, Yusuke Mitsunori, Arihiro Aihara, Daisuke Ban, Takanori Ochiai, Atsushi Kudo, Minoru Tanabe, Shinji Tanaka. Tumor suppressor functions of DAXX through histone H3.3/H3K9me3 pathway in pancreatic NETs. Endocrine-Related Cancer 2018; 25(6): 619 doi: 10.1530/ERC-17-0328
|